CRENESSITY
Live / Applied — First extension granted (statement of use) (as of 21 Jul 2026)
What this means for you
Not registered yet, but its 29 Jan 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99021870
- Mark type
- Design + words
- Filed
- 29 Jan 2025
- Published for opposition
- 15 Jul 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 042 — Scientific and technological services: Providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on other endocrine diseases and disorders; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders, for others; conducting post-authorization pharmaceutical research for the marketing of pharmaceutical preparations and evaluating epidemiological results
- Class 044 — Medical, beauty and agricultural services: Providing medical information; Providing medical information to patients, medical professionals in the field of other endocrine diseases and disorders; Providing medical information to insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals in the field of other endocrine diseases and disorders; on-line information services, namely, providing medical information to insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 08 Sept 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 08 Sept 2026 — TEAS STATEMENT OF USE RECEIVED
- 08 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 22 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jul 2026 — CORRECTED NOA E-MAILED
- 21 Jul 2026 — SOU EXTENSION 1 GRANTED
- 09 Mar 2026 — SOU EXTENSION 1 FILED
- 21 Jul 2026 — DIVISIONAL PROCESSING COMPLETE
- 03 Oct 2025 — DIVISIONAL REQUEST RECEIVED
- 17 Jul 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Oct 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 09 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Jul 2025 — PUBLISHED FOR OPPOSITION